Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association
Guideline
Heart Rhythm
DOI:
10.1093/europace/euae178
Publication Date:
2024-06-28T13:11:21Z
AUTHORS (121)
ABSTRACT
Abstract Aims The aim is to describe the rationale, design, delivery, and baseline characteristics of Stroke prevention rhythm control Treatment: Evaluation an Educational programme European society cardiology in a cluster-Randomized trial patients with Atrial Fibrillation (STEEER-AF) trial. Methods results STEEER-AF pragmatic designed objectively robustly determine whether guidelines are adhered routine practice evaluate targeted educational for healthcare professionals. Seventy centres were randomized six countries (France, Germany, Italy, Poland, Spain, UK; 2022–23). recruited 1732 diagnosis atrial fibrillation (AF), mean age 68.9 years (SD 11.7), CHA2DS2-VASc score 3.2 1.8), 647 (37%) women. Eight hundred forty-three (49%) AF at enrolment 760 (44%) sinus rhythm. Oral anticoagulant therapy was prescribed 1543 (89%), majority receiving direct oral anticoagulants (1378; 89%). Previous cardioversion, antiarrhythmic drug therapy, or ablation recorded 836 (48.3%). Five fifty-one (31.8%) currently drug, 446 (25.8%) scheduled receive future cardioversion ablation. engaged 195 professionals across intervention group, consisting bespoke interactive online learning reinforcement activities, supported by national expert trainers. Conclusion successfully deployed investigate guideline adherence real-world if structured can improve patient-level care. Clinical Trial Registration Clinicaltrials.gov, NCT04396418.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....